Review
doi: 10.1080/14653240410005285.
DC preparations for therapy
Affiliations
- PMID: 15203985
- DOI: 10.1080/14653240410005285
Item in Clipboard
Review
DC preparations for therapy
Cytotherapy.
2004.
Abstract
This review describes and compares the different DC preparations currently under laboratory and clinical investigation as vehicles for cancer immunotherapy.
Similar articles
-
Generation of dendritic cell-based vaccines for cancer therapy.Br J Cancer. 2002 May 20;86(10):1529-33. doi: 10.1038/sj.bjc.6600316. Br J Cancer. 2002. PMID: 12085199 Free PMC article. Review.
-
Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells.J Immunol Methods. 2004 Nov;294(1-2):67-80. doi: 10.1016/j.jim.2004.08.010. J Immunol Methods. 2004. PMID: 15604017
-
DC in multiple myeloma immunotherapy.Cytotherapy. 2004;6(2):128-37. doi: 10.1080/14653240410005357. Cytotherapy. 2004. PMID: 15203989 Review.
-
FastDC derived from human monocytes within 48 h effectively prime tumor antigen-specific cytotoxic T cells.J Immunol Methods. 2005 Jul;302(1-2):145-55. doi: 10.1016/j.jim.2005.05.010. J Immunol Methods. 2005. PMID: 15992809
-
Cryopreservation of monocytes is superior to cryopreservation of immature or semi-mature dendritic cells for dendritic cell-based immunotherapy.J Immunother. 2009 Jul-Aug;32(6):638-54. doi: 10.1097/CJI.0b013e3181a5bc13. J Immunother. 2009. PMID: 19483645
Cited by
-
CIK cells from patients with HCC possess strong cytotoxicity to multidrug-resistant cell line Bel-7402/R.World J Gastroenterol. 2005 Jun 14;11(22):3339-45. doi: 10.3748/wjg.v11.i22.3339. World J Gastroenterol. 2005. PMID: 15948236 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
